嗜血分枝杆菌感染的临床特征与治疗结局
泰国Siriraj医院2012年1月至2017年9月回顾性研究21例嗜血分枝杆菌感染患者,HIV感染为最常见合并症。皮肤软组织受累占60%,大环内酯类联合氟喹诺酮类治疗皮肤感染治愈率60%,加用利福平后治愈率66%。
要点
- HIV感染者更易出现中枢神经系统受累和播散性感染,预后较差。
- 皮肤软组织是最常见感染部位,占60%。
- 中枢神经系统受累患者全部治疗失败。
核心结论
- 嗜血分枝杆菌感染中HIV为最常见合并症,皮肤软组织最常受累。
- 大环内酯类联合氟喹诺酮类治疗皮肤感染治愈率60%,加用利福平后为66%。
- HIV感染者更易出现中枢神经系统受累和播散性感染,预后较差。
研究设计与样本
- 泰国曼谷Siriraj医院2012年1月至2017年9月的回顾性研究,共纳入21例嗜血分枝杆菌感染患者。
主要发现
- HIV感染是最常见的合并症。
- 皮肤软组织受累占60%。
- 大环内酯类联合氟喹诺酮类治疗皮肤感染治愈率60%,加用利福平作为第三种药物后治愈率66%。
- 皮肤、肌肉骨骼和眼部疾病的内科治疗有效率分别为80%、50%和50%。
- 所有中枢神经系统受累患者均治疗失败。
关键数值与推荐
- 皮肤感染:大环内酯类联合氟喹诺酮类治愈率60%,加用利福平后66%。
- 皮肤、肌肉骨骼、眼部疾病内科治疗有效率分别为80%、50%、50%。
临床怎么用
- 对免疫抑制患者,尤其是HIV感染者,应警惕嗜血分枝杆菌感染。
- 皮肤软组织感染可采用大环内酯类联合氟喹诺酮类,重症可加用利福平。
- 中枢神经系统受累提示治疗失败风险高,需密切评估。
局限性
- 回顾性研究,样本量较小(21例)。
- 嗜血分枝杆菌培养条件特殊,可能导致病例报告不足。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Mycobacterium haemophilum is a nontuberculous mycobacterium that can infect immunocompromised patients. Because of special conditions required for its culture, this bacterium is rarely reported and there are scarce data for long-term outcomes. We conducted a retrospective study at Siriraj Hospital, Bangkok, Thailand, during January 2012-September 2017. We studied 21 patients for which HIV infection was the most common concurrent condition. The most common organ involvement was skin and soft tissue (60%). Combination therapy with macrolides and fluoroquinolones resulted in a 60% cure rate for cutaneous infection; adding rifampin as a third drug for more severe cases resulted in modest (66%) cure rate. Efficacy of medical therapy in cutaneous, musculoskeletal, and ocular diseases was 80%, 50%, and 50%, respectively. All patients with central nervous system involvement showed treatment failures. Infections with M. haemophilum in HIV-infected patients were more likely to have central nervous system involvement and tended to have disseminated infections and less favorable outcomes.
引用
- Nookeu P, Angkasekwinai N, Foongladda S, et al. Clinical Characteristics and Treatment Outcomes for Patients Infected with Mycobacterium haemophilum. Emerg Infect Dis. 2019. PMID: 31441427. doi:10.3201/eid2509.190430
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。